Debiński Andrzej, Nowicka Grazyna
Pracownia Metaboliczna Zakładu Profilaktyki Chorób Zywieniowozaleznych z Poradnia Chorób Metabolicznych, Instytutu Zywnogci i Zywienia w Warszawie ul. Powsińska 61/63, 02-903 Warszawa.
Ann Acad Med Stetin. 2004;50 Suppl 1:23-7.
Fluoride is a very potent bone stimulating factor. The aim of the study was to assess the influence of sodium fluoride on bone formation and resorption in the process of experimental ectopic bone formation. Ectopic bone formation was induced 10 days after the start of treatment. Two groups of 15 rats each, study and control, were formed. The study group received 100 ppm sodium fluoride in water. Devitalised bone matrix grafts were implanted intramuscularly in two thorax regions. Eight weeks later the ossicles were removed and prepared without decalcification for histomorphometric analysis. Osteoid perimeter (O.Pm) and osteoblast number (N.Ob) were higher in the study as compared to the control group (42.24 +/- 4.14 vs. 12.18 +/- 2.89; p < 0.01 and 26.07 +/- 3.26 vs. 10.24 +/- 1.39; p < 0.01, respectively). Osteoclast number (N.Oc) was increased in the study group (4.31 +/- 0.40 vs. 2.53 +/- 0.31; p < 0.01). No significant differences in bone area (B.Ar/T.Ar) were found (19.36 +/- 2.26 vs. 18.67 +/- 3.71). It was concluded that sodium fluoride not only increases osteoblast activity but also stimulates bone resorption in bone matrix grafts.
氟化物是一种非常有效的骨刺激因子。本研究的目的是评估氟化钠在实验性异位骨形成过程中对骨形成和吸收的影响。在治疗开始10天后诱导异位骨形成。将大鼠分为两组,每组15只,即研究组和对照组。研究组饮用含100 ppm氟化钠的水。将失活的骨基质移植物植入两个胸部区域的肌肉内。八周后取出小骨,不脱钙进行组织形态计量学分析。与对照组相比,研究组的类骨质周长(O.Pm)和成骨细胞数量(N.Ob)更高(分别为42.24±4.14对12.18±2.89;p<0.01和26.07±3.26对10.24±1.39;p<0.01)。研究组破骨细胞数量(N.Oc)增加(4.31±0.40对2.53±0.31;p<0.01)。骨面积(B.Ar/T.Ar)无显著差异(19.36±2.26对18.67±3.71)。结论是,氟化钠不仅能增加成骨细胞活性,还能刺激骨基质移植物中的骨吸收。